Bill Wang

Bill Wang is a Vice President at AstraZeneca, where they lead Purification Process Sciences and Analytical Sciences, overseeing a portfolio that expanded from under 15 to over 40 clinical development products, including several FDA-approved treatments. With over 20 years of experience in the biopharmaceutical industry, Bill has held leadership roles at organizations such as GSK and Biogen Idec, focusing on process development and manufacturing. Bill has also contributed to the scientific community through publications and participation in professional organizations. They earned a degree from the University of Rochester in 1993.